RORC Gene

Migration, Crosslink

📖

RORC Gene

active

wiki page Created: 2026-04-02T07:19:27 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-rorc

📖 Wiki Page

gene2320 wordssynced 2026-04-02

Overview

RORC (RAR-Related Orphan Receptor C), also known as RORγ, is a nuclear receptor that functions as the core transcriptional driver of the molecular [circadian clock](/mechanisms/circadian-rhythm). Beyond its well-established role in immune function and metabolism, RORC has emerged as a significant regulator of neuronal health, with dysfunction implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions. The RORC-driven circadian program influences sleep-wake cycles, metabolic homeostasis, neuroinflammation, and cellular stress responses—all processes critically affected in neurodegeneration.

...

Overview

RORC (RAR-Related Orphan Receptor C), also known as RORγ, is a nuclear receptor that functions as the core transcriptional driver of the molecular [circadian clock](/mechanisms/circadian-rhythm). Beyond its well-established role in immune function and metabolism, RORC has emerged as a significant regulator of neuronal health, with dysfunction implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative conditions. The RORC-driven circadian program influences sleep-wake cycles, metabolic homeostasis, neuroinflammation, and cellular stress responses—all processes critically affected in neurodegeneration.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">RORC Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>RORC</td></tr>
<tr><td><strong>Full Name</strong></td><td>RAR-Related Orphan Receptor C</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>1q21.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[5873](https://www.ncbi.nlm.nih.gov/gene/5873)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[607037](https://www.omim.org/entry/607037)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000143357</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P51586](https://www.uniprot.org/uniprot/P51586)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Autoimmune Disorders, Metabolic Syndrome</td></tr>
</table>
</div>

Function

Circadian Clock Regulation

RORC functions as one of the core transcription factors driving the molecular circadian clock. The circadian transcriptional-translational feedback loop operates as follows:

Mermaid diagram (expand to render)

Isoforms

| Isoform | Expression | Primary Function |
|---------|------------|-------------------|
| RORC1 (RORγ1) | Thymus, liver, peripheral tissues | Metabolic regulation |
| RORC2 (RORγ2) | Brain, particularly hypothalamus | Circadian rhythm in CNS |

Target Genes

RORC regulates numerous downstream targets including:

Metabolic genes: GLUT4, PEPCK, fatty acid oxidation enzymes
Immune genes: IL-17, IL-22, antimicrobial peptides
Clock genes: NR1D1 (Rev-Erbα), NPAS2
Neuronal genes: Synaptic plasticity factors, neurotransmitter receptors

Protein-Protein Interactions

Core Clock Interactors

RORC interacts with several key proteins within the circadian transcriptional machinery:

Mermaid diagram (expand to render)

Nuclear Receptor Network

RORC participates in a complex network with other nuclear receptors:

REV-ERBα (NR1D1): RORC and REV-ERBα compete for binding at ROREs, creating a mutually exclusive transcriptional switch. REV-ERBα often represses genes that RORC activates.

PPARγ: RORC can cooperate with PPARγ in metabolic gene regulation, potentially linking circadian and metabolic pathways relevant to neurodegeneration.

GR (Glucocorticoid Receptor): Cross-talk between glucocorticoid signaling and RORC may mediate stress-induced circadian disruption.

Retinoic Acid Receptors (RARs): RORC shares structural features with RARs and may be modulated by retinoid signaling.

Co-factors and Co-regulators

| Co-factor | Function | Relevance to Neurodegeneration |
|-----------|----------|--------------------------------|
| p300/CBP | Histone acetylation, transcriptional co-activation | Dysregulated in AD |
| NCoR | Corepressor recruitment | Altered in aging |
| SIRT1 | Deacetylase, metabolic regulation | Declines with age, in AD |
| HDAC3 | Transcriptional repression | Increased in neurodegeneration |
| PGC-1α | Mitochondrial biogenesis | Impaired in PD |

Non-coding RNA Interactions

RORC regulates several miRNAs that influence neurodegeneration:

miR-124: The most abundant miRNA in the brain; RORC directly regulates its expression. miR-124 targets inflammatory genes and is reduced in AD/PD brains.
miR-219: Regulates circadian period length; implicated in sleep disorders associated with neurodegeneration.
miR-132: Linked to synaptic plasticity and memory; RORC may modulate its expression.

Role in Neurodegeneration

Alzheimer's Disease

Circadian disruption is increasingly recognized as both an early symptom and potential contributor to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis. RORC contributes through:

Sleep-wake cycle regulation: RORC in the [suprachiasmatic nucleus](/brain-regions/hypothalamus) drives diurnal rhythms; disruption leads to sundowning and sleep fragmentation

Amyloid homeostasis: Circadian regulation of Aβ production and clearance follows a diurnal pattern—RORC dysfunction may impair this

Tau phosphorylation: Clock genes influence tau pathology through regulation of phosphatases and kinases

Neuroinflammation: RORC regulates the circadian rhythm of inflammatory responses; disruption promotes chronic neuroinflammation

Synaptic plasticity: RORC-dependent transcriptional programs influence memory consolidation during sleep

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), RORC dysfunction may contribute to:

Dopaminergic rhythm disruption: Loss of circadian regulation in dopaminergic neurons
Sleep disorders: REM sleep behavior disorder, a prodromal PD marker
Mitochondrial function: RORC regulates genes involved in mitochondrial dynamics
Neuroinflammation: Circadian modulation of microglial activation states

Mechanistic Pathway

Mermaid diagram (expand to render)

Molecular Mechanisms

RORC Signaling in Neuronal Cells

RORC exerts its effects through multiple molecular pathways in the central nervous system:

Transcriptional Regulation: RORC binds to ROR response elements (RORE) in the promoters of target genes, recruiting co-activators such as p300/CBP to modulate transcription of metabolic and inflammatory genes [@ko2020].

Interaction with BMAL1-CLOCK: The RORC-BMAL1-CLOCK complex forms an integrated circadian transcriptional machinery. BMAL1 promotes RORC expression, while RORC in turn activates metabolic and immune genes in a circadian manner [@choi2021].

NF-κB Cross-talk: RORC can modulate NF-κB signaling through competitive binding at shared target gene promoters. This cross-talk is particularly relevant in microglial cells where inflammatory responses show circadian variation [@xia2023].

Metabolic Regulation: RORC influences mitochondrial function through regulation of genes involved in oxidative phosphorylation, fatty acid oxidation, and ATP production. This is particularly important in neurons with high metabolic demands.

Epigenetic Modulation

Recent research indicates RORC can influence neurodegenerative processes through epigenetic mechanisms:

Histone Acetylation: RORC recruits histone acetyltransferases (HATs) to target gene promoters, altering chromatin accessibility
DNA Methylation: Age-related changes in RORC promoter methylation have been associated with circadian disruption in AD patients
Non-coding RNAs: RORC-regulated microRNAs (e.g., miR-124) influence neuronal survival and neuroinflammation

Expression Patterns

Brain Expression

RORC shows moderate expression in the human brain based on Allen Human Brain Atlas data:

| Region | Expression Level | Functional Significance |
|--------|-----------------|------------------------|
| [Hypothalamus](/brain-regions/hypothalamus) | High | Suprachiasmatic nucleus, circadian pacemaker |
| [Thalamus](/brain-regions/thalamus) | Moderate | Sensory and regulatory relay |
| [Cortex](/brain-regions/cortex) | Low-Moderate | Synaptic function |
| [Hippocampus](/brain-regions/hippocampus) | Low-Moderate | Memory consolidation |

Cell Type Expression

Single-cell expression data from the Allen Brain Cell Atlas indicates RORC is expressed in:

Hypothalamic neurons (particularly in the suprachiasmatic nucleus)
Certain inhibitory neurons (parvalbumin and somatostatin interneurons)
Lower expression in excitatory cortical neurons
Minimal expression in microglia

Clinical Implications

Biomarker Potential

RORC expression or activity may serve as:

A biomarker for circadian dysfunction in neurodegeneration
A predictor of disease progression
A marker for treatment response to circadian-modulating therapies

Diagnostic Applications

Circadian biomarkers related to RORC function include:

Salivary melatonin rhythms: Diminished amplitude in AD/PD patients
Body temperature cycles: Reduced diurnal variation in neurodegeneration
Cortisol circadian patterns: Flattened rhythm associated with disease severity

Therapeutic Targets

RORC agonists: Synthetic ligands that enhance RORC activity may restore circadian function

Chronotherapeutic approaches: Timing of interventions to align with RORC-driven rhythms

Sleep optimization: Interventions that improve sleep quality may indirectly support RORC function

Protein Structure and Function

Domain Architecture

The RORC protein contains several functional domains essential for its role as a nuclear receptor:

N-terminal Domain (A/B Domain): Contains the activation function-1 (AF-1) region responsible for transcriptional activation through interaction with co-activators.

DNA-Binding Domain (DBD, C Domain): Contains two zinc finger motifs that recognize ROR response elements (ROREs) in target gene promoters with the consensus sequence AGGTCA separated by a single nucleotide spacer (AGGTCA N AGGTCA).

Hinge Region (D Domain): Provides flexibility between DBD and LBD; contains nuclear localization signals and sites for post-translational modifications.

Ligand-Binding Domain (LBD, E Domain): Contains the AF-2 activation domain; although RORC is considered an orphan receptor, it may bind endogenous ligands such as heme, cholesterol metabolites, or fatty acids.

Post-Translational Modifications

RORC activity is regulated by several post-translational modifications:

| Modification | Effect | Relevance to Neurodegeneration |
|--------------|--------|--------------------------------|
| Phosphorylation (Ser/Thr) | Alters transcriptional activity, stability | Impaired in AD/PD |
| Acetylation (Lys) | Modulates protein-protein interactions | Dysregulated in aging |
| Sumoylation | Represses transcriptional activity | Changes in neurodegeneration |
| Ubiquitination | Targets for degradation | Altered in disease states |

Animal Models

Genetic Mouse Models

Several rodent models have been developed to study RORC function in neurodegeneration:

RORC knockout mice: Show circadian rhythm abnormalities, metabolic defects, and increased susceptibility to inflammatory challenges.

Conditional neuronal RORC deletion: Exhibits impaired hippocampal-dependent memory and altered synaptic plasticity.

Transgenic RORC overexpression: Demonstrates enhanced circadian amplitude and protection against some forms of neuronal stress.

Phenotypic Characteristics

Circadian behavior: Altered locomotor activity rhythms, fragmented sleep-wake cycles
Metabolism: Dysregulated glucose homeostasis, altered lipid metabolism
Neuroinflammation: Enhanced microglial activation in response to immune challenges
Cognition: Deficits in spatial memory and learning

Limitations of Current Models

Species differences in RORC isoform expression
Partial compensation by other ROR family members
Need for more specific disease-relevant models

Therapeutic Development

Small Molecule Modulators

| Compound | Mechanism | Development Stage | Notes |
|----------|-----------|-------------------|-------|
| SR1078 | RORC agonist | Preclinical | Increases RORC transcriptional activity |
| SR1001 | RORC inverse agonist | Preclinical | Reduces excessive RORC activity |
| SR9009 | RORC agonist | Research | Enhances circadian function |
| SR18292 | RORC antagonist | Research | Modulates neuroinflammation |

Drug Repurposing Opportunities

Several existing drugs may influence RORC activity:

Melatonin: Enhances RORC signaling through downstream pathways
Statins: May affect RORC through cholesterol-dependent mechanisms
HDAC inhibitors: Modify RORC expression through epigenetic mechanisms
NSAIDs: Interfere with NF-κB-RORC cross-talk

Clinical Trials

While no direct RORC-targeted therapies are currently in clinical trials for neurodegenerative diseases, several trials target related pathways:

Melatonin supplementation for sleep disorders in AD/PD (NCT02818290)
Chronotherapy interventions for circadian dysfunction
Light therapy for circadian alignment

Research Directions

Current Areas of Investigation

Single-cell transcriptomics: Profiling RORC expression in specific neuronal populations

CRISPR-based screening: Identifying downstream effectors of RORC in neurodegeneration

Protein-protein interactions: Mapping the RORC interactome in brain cells

Post-translational modifications: Understanding how phosphorylation and acetylation affect RORC function

Gaps in Knowledge

Cell-type specificity: How RORC function differs across neuronal subtypes
Disease stage effects: How RORC dysfunction evolves during disease progression
Sex differences: Potentialgender-specific effects of RORC in neurodegeneration
Therapeutic window: Optimal timing for interventions targeting RORC pathways

Key Publications

[Partch CL, et al. Molecular architecture of the mammalian circadian clock. Trends in Cell Biology (2014)](https://doi.org/10.1016/j.tcb.2014.04.007) — Comprehensive review of circadian clock machinery.

[Sulli G, et al. Interconnection between circadian clock and neurodegeneration. Nature Reviews Neurology (2019)](https://doi.org/10.1038/s41582-019-0221-1) — Direct link between clock dysfunction and neurodegeneration.

[Musiek ES, Holtzman DM. Disruption of circadian clocks and neurodegeneration. Neurobiology of Aging (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.04.008) — Evidence for bidirectional relationship.

[Jetten AM, et al. Retinoid-related orphan receptors: Critical roles in development and disease. BBA (2018)](https://pubmed.ncbi.nlm.nih.gov/29306962/) — Comprehensive ROR family review.

[Song I, et al. Circadian rhythm dysfunction as a biomarker in Alzheimer's disease. Front Aging Neurosci (2022)](https://pubmed.ncbi.nlm.nih.gov/35401152/) — Clinical implications.

[Ko CH, et al. RORs as potential therapeutic targets for neurodegenerative diseases. J Biomed Sci (2020)](https://doi.org/10.1186/s12929-020-00674-5) — Therapeutic potential.

[Uchoa ET, et al. Circadian disruption and neuroinflammation in Alzheimer's disease. Prog Neuropsychopharmacol (2022)](https://doi.org/10.1016/j.pnpbp.2022.110551) — Neuroinflammation link.

[Xia L, et al. Role of RORC in neuroinflammation and microglial activation. Cell Mol Neurobiol (2023)](https://doi.org/10.1007/s10571-023-01326-8) — Microglial mechanisms.

[Park J, et al. Circadian rhythm alterations in Parkinson's disease. Mov Disord (2021)](https://doi.org/10.1002/mds.28406) — PD-specific effects.

[Yang L, et al. RORC modulates neuroinflammation via NF-κB pathway in AD. J Neuroinflammation (2022)](https://doi.org/10.1186/s12974-022-02504-4) — Molecular pathway.

[Liu X, et al. Melatonin and RORC signaling in tau pathology. Aging Cell (2023)](https://doi.org/10.1111/acel.13845) — Tau pathology connection.

[Schneider A, et al. RORC variants in neurodegenerative disease. Hum Mol Genet (2019)](https://doi.org/10.1093/hmg/ddz123) — Genetic variants.

[Choi JE, et al. BMAL1-RORC transcriptional circuit in dopaminergic neurons. Neurobiol Dis (2021)](https://doi.org/10.1016/j.nbd.2021.105234) — Dopaminergic neurons.

[Khan S, et al. Sleep disruption and amyloid burden in preclinical AD. Brain (2022)](https://doi.org/10.1093/brain/awab467) — Sleep-amyloid link.

[Ross CA, et al. Nuclear receptors as metabolic sensors in brain aging. Nat Rev Endocrinol (2018)](https://doi.org/10.1038/s41574-018-0049-1) — Metabolic regulation.

References

[Partch CL, et al. Molecular architecture of the mammalian circadian clock. Trends in Cell Biology (2014)](https://doi.org/10.1016/j.tcb.2014.04.007)

[Sulli G, et al. Interconnection between circadian clock and neurodegeneration. Nature Reviews Neurology (2019)](https://doi.org/10.1038/s41582-019-0221-1)

[Musiek ES, Holtzman DM. Disruption of circadian clocks and neurodegeneration. Neurobiology of Aging (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.04.008)

[Jetten AM, et al. Retinoid-related orphan receptors: Critical roles in development and disease. BBA (2018)](https://pubmed.ncbi.nlm.nih.gov/29306962/)

[Song I, et al. Circadian rhythm dysfunction as a biomarker in Alzheimer's disease. Front Aging Neurosci (2022)](https://pubmed.ncbi.nlm.nih.gov/35401152/)

[Ko CH, et al. RORs as potential therapeutic targets for neurodegenerative diseases. J Biomed Sci (2020)](https://doi.org/10.1186/s12929-020-00674-5)

[Uchoa ET, et al. Circadian disruption and neuroinflammation in Alzheimer's disease. Prog Neuropsychopharmacol (2022)](https://doi.org/10.1016/j.pnpbp.2022.110551)

[Xia L, et al. Role of RORC in neuroinflammation and microglial activation. Cell Mol Neurobiol (2023)](https://doi.org/10.1007/s10571-023-01326-8)

[Park J, et al. Circadian rhythm alterations in Parkinson's disease. Mov Disord (2021)](https://doi.org/10.1002/mds.28406)

[Yang L, et al. RORC modulates neuroinflammation via NF-κB pathway in AD. J Neuroinflammation (2022)](https://doi.org/10.1186/s12974-022-02504-4)

[Liu X, et al. Melatonin and RORC signaling in tau pathology. Aging Cell (2023)](https://doi.org/10.1111/acel.13845)

[Schneider A, et al. RORC variants in neurodegenerative disease. Hum Mol Genet (2019)](https://doi.org/10.1093/hmg/ddz123)

[Choi JE, et al. BMAL1-RORC transcriptional circuit in dopaminergic neurons. Neurobiol Dis (2021)](https://doi.org/10.1016/j.nbd.2021.105234)

[Khan S, et al. Sleep disruption and amyloid burden in preclinical AD. Brain (2022)](https://doi.org/10.1093/brain/awab467)

[Ross CA, et al. Nuclear receptors as metabolic sensors in brain aging. Nat Rev Endocrinol (2018)](https://doi.org/10.1038/s41574-018-0049-1)

Pathway Diagram

The following diagram shows the key molecular relationships involving RORC Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

RORC

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-rorc
kg_node_id	RORC
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-a0cbe2a7bba0
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rorc'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

23

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

RORC Gene

RORC Gene — RAR-Related Orphan Receptor C

Overview

RORC Gene — RAR-Related Orphan Receptor C

Overview

Function

Circadian Clock Regulation

Isoforms

Target Genes

Protein-Protein Interactions

Core Clock Interactors

Nuclear Receptor Network

Co-factors and Co-regulators

Non-coding RNA Interactions

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Mechanistic Pathway

Molecular Mechanisms

RORC Signaling in Neuronal Cells

Epigenetic Modulation

Expression Patterns

Brain Expression

Cell Type Expression

Clinical Implications

Biomarker Potential

Diagnostic Applications

Therapeutic Targets

Protein Structure and Function

Domain Architecture

Post-Translational Modifications

Animal Models

Genetic Mouse Models

Phenotypic Characteristics

Limitations of Current Models

Therapeutic Development

Small Molecule Modulators

Drug Repurposing Opportunities

Clinical Trials

Research Directions

Current Areas of Investigation

Gaps in Knowledge

Key Publications

See Also

References

Pathway Diagram

💬 Discussion